Johnson & Johnson Price to Sales Ratio 2006-2021 | JNJ
For a detailed definition, formula and example for P/S Ratio, check out our new background page here.
Historical PS ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current P/S ratio for Johnson & Johnson as of September 17, 2021 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Johnson & Johnson P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2021-09-17 |
164.75 |
|
4.93 |
| 2021-06-30 |
163.76 |
$33.39 |
4.90 |
| 2021-03-31 |
162.37 |
$31.54 |
5.15 |
| 2020-12-31 |
154.52 |
$30.94 |
4.99 |
| 2020-09-30 |
145.15 |
$30.25 |
4.80 |
| 2020-06-30 |
136.20 |
$30.12 |
4.52 |
| 2020-03-31 |
126.12 |
$30.88 |
4.08 |
| 2019-12-31 |
139.39 |
$30.55 |
4.56 |
| 2019-09-30 |
122.78 |
$30.30 |
4.05 |
| 2019-06-30 |
132.18 |
$29.99 |
4.41 |
| 2019-03-31 |
131.76 |
$30.01 |
4.39 |
| 2018-12-31 |
120.84 |
$29.91 |
4.04 |
| 2018-09-30 |
128.56 |
$29.79 |
4.31 |
| 2018-06-30 |
112.15 |
$29.51 |
3.80 |
| 2018-03-31 |
117.58 |
$28.73 |
4.09 |
| 2017-12-31 |
127.38 |
$27.86 |
4.57 |
| 2017-09-30 |
117.81 |
$26.99 |
4.36 |
| 2017-06-30 |
119.12 |
$26.21 |
4.54 |
| 2017-03-31 |
111.41 |
$25.95 |
4.29 |
| 2016-12-31 |
102.39 |
$25.74 |
3.98 |
| 2016-09-30 |
104.26 |
$25.58 |
4.08 |
| 2016-06-30 |
106.35 |
$25.27 |
4.21 |
| 2016-03-31 |
94.20 |
$24.98 |
3.77 |
| 2015-12-31 |
88.79 |
$24.90 |
3.57 |
| 2015-09-30 |
80.10 |
$24.94 |
3.21 |
| 2015-06-30 |
82.98 |
$25.29 |
3.28 |
| 2015-03-31 |
85.03 |
$25.75 |
3.30 |
| 2014-12-31 |
87.77 |
$25.91 |
3.39 |
| 2014-09-30 |
88.89 |
$25.91 |
3.43 |
| 2014-06-30 |
86.66 |
$25.56 |
3.39 |
| 2014-03-31 |
80.81 |
$24.96 |
3.24 |
| 2013-12-31 |
74.80 |
$24.78 |
3.02 |
| 2013-09-30 |
70.31 |
$24.65 |
2.85 |
| 2013-06-30 |
69.13 |
$24.60 |
2.81 |
| 2013-03-31 |
65.15 |
$24.30 |
2.68 |
| 2012-12-31 |
55.57 |
$24.00 |
2.32 |
| 2012-09-30 |
54.15 |
$23.61 |
2.29 |
| 2012-06-30 |
52.61 |
$23.32 |
2.26 |
| 2012-03-31 |
50.88 |
$23.40 |
2.17 |
| 2011-12-31 |
50.14 |
$23.42 |
2.14 |
| 2011-09-30 |
48.25 |
$23.17 |
2.08 |
| 2011-06-30 |
49.95 |
$22.79 |
2.19 |
| 2011-03-31 |
44.10 |
$22.30 |
1.98 |
| 2010-12-31 |
45.63 |
$22.06 |
2.07 |
| 2010-09-30 |
45.32 |
$22.38 |
2.02 |
| 2010-06-30 |
42.79 |
$22.40 |
1.91 |
| 2010-03-31 |
46.81 |
$22.40 |
2.09 |
| 2009-12-31 |
45.89 |
$22.20 |
2.07 |
| 2009-09-30 |
43.05 |
$21.62 |
1.99 |
| 2009-06-30 |
39.84 |
$21.84 |
1.82 |
| 2009-03-31 |
36.56 |
$22.15 |
1.65 |
| 2008-12-31 |
41.24 |
$22.41 |
1.84 |
| 2008-09-30 |
47.38 |
$22.54 |
2.10 |
| 2008-06-30 |
43.72 |
$22.05 |
1.98 |
| 2008-03-31 |
43.78 |
$21.45 |
2.04 |
| 2007-12-31 |
44.72 |
$20.94 |
2.14 |
| 2007-09-30 |
43.78 |
$20.08 |
2.18 |
| 2007-06-30 |
40.78 |
$19.45 |
2.10 |
| 2007-03-31 |
39.62 |
$18.76 |
2.11 |
| 2006-12-31 |
43.16 |
$17.96 |
2.40 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$434.939B |
$82.584B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
